DekaBank Deutsche Girozentrale - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,930
+72.7%
17,0000.0%0.01%
+75.0%
Q2 2023$1,697
+12.8%
17,0000.0%0.00%0.0%
Q1 2023$1,505
+82.2%
17,000
-24.9%
0.00%
+100.0%
Q4 2022$826
-99.9%
22,6400.0%0.00%0.0%
Q3 2022$559,000
-21.3%
22,6400.0%0.00%0.0%
Q2 2022$710,000
+38.1%
22,640
+36.1%
0.00%
+100.0%
Q1 2022$514,000
+44.0%
16,640
+9.9%
0.00%0.0%
Q4 2021$357,000
-76.7%
15,140
+2.7%
0.00%
-75.0%
Q3 2021$1,529,000
-28.3%
14,7400.0%0.00%
-33.3%
Q2 2021$2,133,000
+52.0%
14,7400.0%0.01%
+20.0%
Q1 2021$1,403,000
-25.6%
14,7400.0%0.01%
-28.6%
Q4 2020$1,886,000
-66.1%
14,740
-75.6%
0.01%
-72.0%
Q3 2020$5,560,000
+424.0%
60,390
+762.7%
0.02%
+257.1%
Q2 2020$1,061,000
-17.4%
7,000
-20.5%
0.01%
-30.0%
Q1 2020$1,284,000
-18.7%
8,800
+17.3%
0.01%0.0%
Q4 2019$1,579,000
-61.9%
7,500
-83.4%
0.01%
-52.4%
Q2 2019$4,147,000
+549.0%
45,300
+512.2%
0.02%
+425.0%
Q1 2019$639,000
-45.9%
7,400
-67.3%
0.00%
-50.0%
Q4 2018$1,182,000
+85.0%
22,650
+206.1%
0.01%
+100.0%
Q3 2018$639,000
+139.3%
7,400
-2.6%
0.00%
+100.0%
Q2 2018$267,000
+75.7%
7,6000.0%0.00%
+100.0%
Q1 2018$152,0007,6000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$76,391,00014.09%
Opaleye Management Inc. 330,000$8,702,0001.85%
Highlander Partners, L.P. 27,600$728,0000.89%
Ikarian Capital, LLC 200,000$5,274,0000.79%
Integral Health Asset Management, LLC 103,000$2,716,0000.75%
KRS Capital Management, LLC 32,841$866,0000.74%
Ghost Tree Capital, LLC 55,000$1,450,0000.52%
MADDEN SECURITIES Corp 39,312$1,037,0000.49%
LBJ Family Wealth Advisors, Ltd. 30,359$801,0000.47%
Ikarian Capital, LLC 100,000$2,637,0000.39%
View complete list of REATA PHARMACEUTICALS INC shareholders